Efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injection
AIM: To explore the efficacy of minimally invasive vitrectomy (MIV) with or without internal limiting membrane (ILM) peeling on the treatment of diabetic macular edema (DME) in proliferative diabetic retinopathy (PDR) combining with preoperative anti-vascular endothelial growth factor (anti-VEGF) in...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2020-11-01
|
Series: | International Journal of Ophthalmology |
Subjects: | |
Online Access: | http://ies.ijo.cn/en_publish/2020/11/20201112.pdf |
id |
doaj-193175def7af463fa736aa55b90f63cb |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jing Guo Xue Bi Shan-Na Chen Song Chen Guang-Hui He Bin Wu Wei Zhang Jian Wang |
spellingShingle |
Jing Guo Xue Bi Shan-Na Chen Song Chen Guang-Hui He Bin Wu Wei Zhang Jian Wang Efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injection International Journal of Ophthalmology proliferative diabetic retinopathy macular edema vitreous macular traction internal limiting membrane minimally invasive vitrectomy anti-vascular endothelial growth factor |
author_facet |
Jing Guo Xue Bi Shan-Na Chen Song Chen Guang-Hui He Bin Wu Wei Zhang Jian Wang |
author_sort |
Jing Guo |
title |
Efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injection |
title_short |
Efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injection |
title_full |
Efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injection |
title_fullStr |
Efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injection |
title_full_unstemmed |
Efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injection |
title_sort |
efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injection |
publisher |
Press of International Journal of Ophthalmology (IJO PRESS) |
series |
International Journal of Ophthalmology |
issn |
2222-3959 2227-4898 |
publishDate |
2020-11-01 |
description |
AIM: To explore the efficacy of minimally invasive vitrectomy (MIV) with or without internal limiting membrane (ILM) peeling on the treatment of diabetic macular edema (DME) in proliferative diabetic retinopathy (PDR) combining with preoperative anti-vascular endothelial growth factor (anti-VEGF) injection.
METHODS: Totally 132 eyes (132 patients) diagnosed PDR with DME were included between June 2015 and June 2018 in Tianjin Eye Hospital. The single MIV treatment group included 68 eyes and the MIV combined with ILM peeling group included 64 eyes. Anti-VEGF drugs were injected intravitreally 1wk before the operation and the period of follow-up was 1 to 3y. Best-corrected visual acuity (BCVA), central retinal thickness (CRT), total macular volume (TMV), macular edema (ME) severity, intraocular pressure (IOP), and complications were recorded. Prognostic factors of visual acuity following ILM peeling were analyzed.
RESULTS: The BCVA was higher than preoperative values at 1, 3, 6, and 12mo after surgery in both groups (all P<0.05). At 6 and 12mo, the BCVA of the combined group was significantly higher than that of the MIV only group (0.52±0.23 vs 0.64±0.29 logMAR, P=0.011 in 6mo; 0.41±0.25 vs 0.52±0.25 logMAR, P=0.008 in 12mo). Mean CRT values postoperative were significantly lower than preoperative values in both groups from the 1st month (1mo 397.65±106.18 vs 451.94±118.88 μm in MIV only group; 388.88±108.68 vs 464.36±111.53 μm in combined group; both P<0.05) and decreased gradually. The differences between the two groups were statistically significant at 3, 6, and 12mo (P=0.004, 0.003, 0.00 respectively). The TMV was decreased from the 3rd month in the single treatment group (3mo 11.14±1.66 vs 12.20±2.09 mm3, P<0.05). At 12mo, the proportion of eyes with edema that had CRT more than 350 μm was significantly lower than before surgery (13.24% vs 77.94% in MIV only group; 1.56% vs 81.25% in combined group; both P<0.05). There was no significant difference in the recurrence incidence of macular epiretinal membrane, ME, transient IOP increase, vitreous rebleeding, or traction retinal detachment between the two groups. BCVA after ILM excision was positively correlated with the CRT and ME degree before and after surgery (r=0.430, 0.485, respectively; P<0.05).
CONCLUSION: MIV combined with ILM peeling accelerates the absorption of ME, improves vision, reduces the postoperative CRT and TMV, and reduces the recurrence rate of postoperative ME. |
topic |
proliferative diabetic retinopathy macular edema vitreous macular traction internal limiting membrane minimally invasive vitrectomy anti-vascular endothelial growth factor |
url |
http://ies.ijo.cn/en_publish/2020/11/20201112.pdf |
work_keys_str_mv |
AT jingguo efficacyofinternallimitingmembranepeelingfordiabeticmacularedemaafterpreoperativeantivascularendothelialgrowthfactorinjection AT xuebi efficacyofinternallimitingmembranepeelingfordiabeticmacularedemaafterpreoperativeantivascularendothelialgrowthfactorinjection AT shannachen efficacyofinternallimitingmembranepeelingfordiabeticmacularedemaafterpreoperativeantivascularendothelialgrowthfactorinjection AT songchen efficacyofinternallimitingmembranepeelingfordiabeticmacularedemaafterpreoperativeantivascularendothelialgrowthfactorinjection AT guanghuihe efficacyofinternallimitingmembranepeelingfordiabeticmacularedemaafterpreoperativeantivascularendothelialgrowthfactorinjection AT binwu efficacyofinternallimitingmembranepeelingfordiabeticmacularedemaafterpreoperativeantivascularendothelialgrowthfactorinjection AT weizhang efficacyofinternallimitingmembranepeelingfordiabeticmacularedemaafterpreoperativeantivascularendothelialgrowthfactorinjection AT jianwang efficacyofinternallimitingmembranepeelingfordiabeticmacularedemaafterpreoperativeantivascularendothelialgrowthfactorinjection |
_version_ |
1724668907389714432 |
spelling |
doaj-193175def7af463fa736aa55b90f63cb2020-11-25T03:07:50ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982020-11-0113111758176410.18240/ijo.2020.11.12Efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injectionJing Guo0Xue Bi1Shan-Na Chen2Song Chen3Guang-Hui He4Bin Wu5Wei Zhang6Jian Wang7Clinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China; Department of Ophthalmology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510120, Guangdong Province, ChinaClinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China; Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin 300020, ChinaClinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China; Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin 300020, China; Xiamen Kehong Eye Hospital, Xiamen 361000, Fujian Province, ChinaClinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China; Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin 300020, ChinaClinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China; Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin 300020, ChinaClinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China; Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin 300020, ChinaClinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China; Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin 300020, ChinaClinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China; Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin 300020, ChinaAIM: To explore the efficacy of minimally invasive vitrectomy (MIV) with or without internal limiting membrane (ILM) peeling on the treatment of diabetic macular edema (DME) in proliferative diabetic retinopathy (PDR) combining with preoperative anti-vascular endothelial growth factor (anti-VEGF) injection. METHODS: Totally 132 eyes (132 patients) diagnosed PDR with DME were included between June 2015 and June 2018 in Tianjin Eye Hospital. The single MIV treatment group included 68 eyes and the MIV combined with ILM peeling group included 64 eyes. Anti-VEGF drugs were injected intravitreally 1wk before the operation and the period of follow-up was 1 to 3y. Best-corrected visual acuity (BCVA), central retinal thickness (CRT), total macular volume (TMV), macular edema (ME) severity, intraocular pressure (IOP), and complications were recorded. Prognostic factors of visual acuity following ILM peeling were analyzed. RESULTS: The BCVA was higher than preoperative values at 1, 3, 6, and 12mo after surgery in both groups (all P<0.05). At 6 and 12mo, the BCVA of the combined group was significantly higher than that of the MIV only group (0.52±0.23 vs 0.64±0.29 logMAR, P=0.011 in 6mo; 0.41±0.25 vs 0.52±0.25 logMAR, P=0.008 in 12mo). Mean CRT values postoperative were significantly lower than preoperative values in both groups from the 1st month (1mo 397.65±106.18 vs 451.94±118.88 μm in MIV only group; 388.88±108.68 vs 464.36±111.53 μm in combined group; both P<0.05) and decreased gradually. The differences between the two groups were statistically significant at 3, 6, and 12mo (P=0.004, 0.003, 0.00 respectively). The TMV was decreased from the 3rd month in the single treatment group (3mo 11.14±1.66 vs 12.20±2.09 mm3, P<0.05). At 12mo, the proportion of eyes with edema that had CRT more than 350 μm was significantly lower than before surgery (13.24% vs 77.94% in MIV only group; 1.56% vs 81.25% in combined group; both P<0.05). There was no significant difference in the recurrence incidence of macular epiretinal membrane, ME, transient IOP increase, vitreous rebleeding, or traction retinal detachment between the two groups. BCVA after ILM excision was positively correlated with the CRT and ME degree before and after surgery (r=0.430, 0.485, respectively; P<0.05). CONCLUSION: MIV combined with ILM peeling accelerates the absorption of ME, improves vision, reduces the postoperative CRT and TMV, and reduces the recurrence rate of postoperative ME.http://ies.ijo.cn/en_publish/2020/11/20201112.pdfproliferative diabetic retinopathymacular edemavitreous macular tractioninternal limiting membraneminimally invasive vitrectomyanti-vascular endothelial growth factor |